SCHEMBL13579554

SCHEMBL13579554

Cn1ncc2cnc3c(cc(I)n3S(C)(=O)=O)c21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2318104 0.82 PTGDR2 (0.36) —
SCHEMBL13579549 0.72 HTR6 (0.35) —
SCHEMBL13580578 0.71 TP53 (0.36) —
SCHEMBL17226416 0.67 — —
SCHEMBL2320310 0.66 LATS1 (0.37) —
SCHEMBL2314750 0.66 PTGS1 (0.37) —
SCHEMBL2319238 0.64 CYP11B1 (0.39) —
SCHEMBL2319349 0.64 MAPT (0.41) —
SCHEMBL16517899 0.62 CCNK (0.38) —
SCHEMBL1536826 0.62 L3MBTL1 (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160326181-A1 NOVEL TRICYCLIC COMPOUNDS ABBVIE INC. (US) 2016-11-10 — — US disclosed
US-9365579-B2 Tricyclic compounds ABBVIE INC. (US) 2016-06-14 — — US disclosed
US-20150210708-A1 NOVEL TRICYCLIC COMPOUNDS ABBVIE INC. (US) 2015-07-30 — — US disclosed
US-8962629-B2 Tricyclic compounds ABBVIE INC. (US) 2015-02-24 — — US disclosed
US-20090312338-A1 Novel Tricyclic Compounds ABBOTT LABORATORIES (US) 2009-12-17 — — US disclosed
Send feedback